Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (12456)	8/1/1998 9:35:00 PM
From: KHS	Read Replies (4) \| Respond to of 23519

VLAD, Nice to see shareholders want answers now. If the shareholders on this thread feel this way, i am sure VVUS is feeling pressure from large holders and institutions. Until we hear something, I feel like this boat is floating with the currents and out of control. Never like to feel out of control!!!

To: VLAD who wrote (12456)	8/2/1998 3:19:00 PM
From: Rocon	Read Replies (3) \| Respond to of 23519

VLAD: Do you or anyone on this thread have a realistic timetable for when Vivus might receive FDA approval for Alibra? This would undoubtedly play heavily to VVUS's advantage in their negotiations to sell the company. Your mentioning of using VVUS as a pure R&D operation is something I never thought of, and it sounds like a logical move considering their depletion of direct marketing personnel. Let's hope you're right about hiring an investment banker to negotiate a sale. I think most of us would be happy with $20/share....... Ron